首页> 外国专利> Preparation and characterization of methylene blue nanoparticles for Alzheimer's disease and other tauopathies

Preparation and characterization of methylene blue nanoparticles for Alzheimer's disease and other tauopathies

机译:用于阿尔茨海默氏病和其他疾病的亚甲蓝纳米颗粒的制备和表征

摘要

A delivery system of coated and uncoated nanoparticles (NP) for delivery of methylene blue (MB). The delivery system was developed using PLGA-based polymer that was repeatedly shown to be biocompatible and biodegradable. The parameters of synthesized NPs were within the suitable range for BBB permeation—specifically, the NPs were monodispersed, with slight negative charge, and with the size within 100-150 nm range suitable for intravenous delivery and delivery to the brain. The coating on the nanoparticle did not have a significant impact on the nanoparticle size and zeta potential. Based on the immunoblotting experiments using AD cellular model, the GSH coated NPs were better in reducing tau levels compared to MB solution. In vitro BBB Transwell permeation study showed eight fold higher MB-NP permeation compared to the MB solution over 24 hours.
机译:涂覆和未涂覆的纳米颗粒(NP)的输送系统,用于输送亚甲基蓝(MB)。该输送系统是使用基于PLGA的聚合物开发的,该聚合物反复被证明具有生物相容性和可生物降解性。合成的NPs的参数在BBB渗透的合适范围内-具体来说,NPs是单分散的,带有少量负电荷,大小在100-150 nm范围内,适合静脉内输送和输送到大脑。纳米颗粒上的涂层对纳米颗粒尺寸和ζ电势没有显着影响。根据使用AD细胞模型进行的免疫印迹实验,与MB溶液相比,GSH包被的NP在降低tau含量方面表现更好。体外BBB Transwell渗透研究表明,在24小时内,MB-NP的渗透率比MB溶液高8倍。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号